Project Details
Description
MT2018-06 :SINGLE-ARM, OPEN LABEL, INTERVENTIONAL PHASE II CLINICAL TRIAL EVALUATING MGTA-456 IN PATIENTS WITH HIGH-RISK MALIGNANCY
Status | Finished |
---|---|
Effective start/end date | 12/18/18 → 12/19/23 |
Funding
- MAGENTA THERAPEUTICS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.